iiinova — where your digital self keeps evolving

ASPET Journals @aspetjournals.bsky.social · 16h

ASPET Discovery is planning a new special collection titled “Advancing Pharmacology Education: Innovations, Evidence, and Emerging Directions.” The deadline is April 15, 2027. Learn more about this special collection, and submit your work, at: ow.ly/Cux550ZXzcl #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 14/10/2026

Are you a trainee, or know one, interested in "Advanced Modalities in Drug Development?" If so, make sure to check out this special issue, and $5,000 award, from the PhRMA Foundation and Drug Metabolism and Disposition: ow.ly/88am50ZVTJM #pharmsky 🧪

002

ASPET Journals @aspetjournals.bsky.social · 14/10/2026

Samantha Serna, a PhD Candidate, is the Molecular Pharmacology Highlighted Trainee Author for October 2026. Her work aims to mitigate respiratory irritation or damage caused by inhaled environmental pollutants through kinase inhibitor-based pharmacological intervention: ow.ly/K4at50ZV0Gv

000

ASPET Journals @aspetjournals.bsky.social · 13/10/2026

ASPET is pleased to announce that Dr. Nina Isoherranen has been selected as the new Editor-in-Chief of Drug Metabolism and Disposition, effective January 1, 2027. Read more about her research interests and background: ow.ly/LFMp50ZWOqE #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 12/10/2026

Why do some individuals develop depression, addiction, or other stress-related disorders while others remain resilient? In this webinar on October 22, two emerging leaders in neuropharmacology will tackle this urgent question: ow.ly/SsYu50ZVCGR #pharmsky 🧪

020

ASPET Journals @aspetjournals.bsky.social · 09/10/2026

Olufunke Ajeigbe, PhD, a Postdoctoral Fellow, is the JPET HTA for October 2026. Her research investigates the short- and long-term effects of an acute high dose of THC, the primary psychoactive compound in cannabis, in adult male and female rats: doi.org/10.1016/j.jpet.2026.105033

000

ASPET Journals @aspetjournals.bsky.social · 08/10/2026

Call for abstracts is now open! Get visibility for your work—present your poster to over 1,000 pharmacology researchers, students, and industry professionals at ASPET 2027. 📆 Deadline: December 3 🔗 www.aspet.org/aspet/meetings-awards…

000

ASPET Journals @aspetjournals.bsky.social · 08/10/2026

JPET is planning a new special collection titled, "Computational Systems Pharmacology and Docking In Signal Pathways Analysis and Modulation for Neurodegenerative Diseases." Submissions are due March 15, 2027. Learn more: ow.ly/LRne50ZUXWP #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 07/10/2026

The Pharmacology Learning Objectives support faculty in developing, delivering, and assessing pharmacology content, with the flexibility to adapt them to the goals, structure, and instructional time of individual curricula. Download your copy: ow.ly/P6w850ZUEHP #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 06/10/2026

In JPET's editor's choice, data provides multiple potential pharmacological targets to prevent prostate cancer metastasis, and circDOPEY2 can be used as a biomarker to track the increased likelihood of prostate cancer metastasis. Read the research: ow.ly/WTVf50ZUC55 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 05/10/2026

Join ASPET for a webinar where faculty and graduate students from Boston University School of Medicine share what to expect from their pharmacology program. Register: ow.ly/Enz950ZUqQp This webinar is open to anyone interested in learning about graduate-level pharmacology! #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 05/10/2026

Advocate for science policy! ASPET’s Government Affairs and Science Policy staff will visit you and your staff, or meet with you virtually, and provide on-hands guidance on how your voice can be heard. Learn how to arrange a visit this fall or next spring: ow.ly/meZ750ZTxbz #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 02/10/2026

Aurora Authement, PhD, is the Drug Metabolism and Disposition Highlighted Trainee Author for September 2026. Her research shows that mechanistic binding models can explain plasma protein binding using clinical data: doi.org/10.1016/j.dmd.2026.100362

000

ASPET Journals @aspetjournals.bsky.social · 01/10/2026

Improve your resume with a professional review on the new ASPET Career Center. Check for issues such as formatting mistakes, keyword gaps, weak wording, and areas that may prevent you from passing applicant tracking systems (ATS). It's free - claim yours today. careers.aspet.org

000

ASPET Journals @aspetjournals.bsky.social · 01/10/2026

Today is the LAST DAY to apply to bring SURF to your institution, and help introduce undergraduate students to pharmacology research. Learn more and apply: ow.ly/xT5k50ZQjMr #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 29/09/2026

Mifepristone’s history is as much a story of scientific discovery as it is one of advocacy, politics, and access. Explore how a medicine repeatedly supported by clinical evidence became one of the most closely scrutinized—and contested—drugs in reproductive health: ow.ly/mZR350ZSoqe

000

ASPET Journals @aspetjournals.bsky.social · 29/09/2026

The JPET section "Clinical Pharmacology" has been established to underscore the critical role that clinical pharmacology plays in advancing human health. Learn more and contribute your research: ow.ly/JbVi50ZFOPE #pharmsky 🧪

011

ASPET Journals @aspetjournals.bsky.social · 28/09/2026

Join ASPET for a webinar designed for students exploring graduate studies in pharmacology, open to BOTH members and non-members! Faculty and graduate students from Boston University will share what to expect from their pharmacology training program: ow.ly/rsqw50ZR5k3 #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 28/09/2026

The PhRMA Foundation and Drug Metabolism and Disposition are partnering on a special issue, and the first author of up to five winning papers will win a Challenge Award of $5,000! Apply by February 1, 2027: ow.ly/JfNF50ZQXFK #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 25/09/2026

In our recent Editor's Choice, research supports dietary glycine potential as a safe strategy for autoimmune hepatobiliary and pancreatic diseases. Learn more about the research from the team at Juntendo University Graduate School of Medicine: ow.ly/YSpW50ZQZE1 #pharmsky 🧪

021

ASPET Journals @aspetjournals.bsky.social · 25/09/2026

Interested in introducing undergraduate students to pharmacology research? Learn how to bring SURF to your campus! Deadline: October 1, 2026. ow.ly/ZePx50ZQjMT #pharmsky 🧪

020

ASPET Journals @aspetjournals.bsky.social · 24/09/2026

Researchers from Emory University Department of Medicine propose oleoylethanolamide may be the endogenous ligand for the orphan GPCR GPR3. It stimulates cAMP formation over hours and promotes recruitment of GPR3 to the cell surface thereby increasing signaling: ow.ly/sf7v50ZQ7hC #pharmsky 🧪

111

ASPET Journals @aspetjournals.bsky.social · 24/09/2026

Check out the ASPET blog on Pharmaco Corner, and read how Dr. Tri Widyawati's experiences at three different World Congresses of Pharmacology shaped her understanding of community and collaboration. Read the blog at ow.ly/l5k550ZJB7K. IUPHAR/BPS Guide to Pharmacology #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 23/09/2026

Don't miss out on tomorrow's webinar, which will highlight emerging opportunities to identify and exploit cancer-specific vulnerabilities, advancing the development of innovative precision therapies. Register here: ow.ly/maw750ZPE9T #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 21/09/2026

Submit your research by December 30 for JPET's upcoming collection, "Peptide-Based Therapeutics for Tumor Immunomodulation." Learn more at ow.ly/a8hZ50ZPEEr #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 18/09/2026

To close out Peer Review Week, we asked John Schuetz, PhD, FASPET, and Editor-in-Chief of ASPET Discovery, for his thoughts on the advancement of AI in scientific publishing. Learn more about ASPET Discovery: www.aspetdiscovery.org #peerreview #peerreviewweek #prw2026 #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 18/09/2026

Today's the final day to submit your application for ASPET'S Editorial Fellowship program! Don't miss this opportunity to learn all aspects of the submission process, peer review, and editorial decisions for scientific journals: bit.ly/4xETeTx #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 17/09/2026

Has attracting reviewers grown more difficult in scientific publishing? Lynette Daws, PhD, and Editor-in-Chief of Pharmacological Reviews, discussed how her journal has met the challenge. Learn more about Pharmacological Reviews: pharmrev.aspetjournals.org #prw2026 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 16/09/2026

Has the process of peer review fundamentally changed in scientific publishing? We asked John Tesmer, PhD, and Editor-in-Chief of Molecular Pharmacology, for his thoughts. Learn more about Molecular Pharmacology: molpharm.aspetjournals.org #peerreviewweek #peerreview #prw2026 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 16/09/2026

ASPET's Editorial Fellowship program, designed to build important skills as a peer reviewer and as an editor in scientific publishing, is perfect for senior post-doctoral fellows and junior faculty members. Send in your applications by this Friday: bit.ly/4xETeTx #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 15/09/2026

NOTE: This webinar is open to all interested in attending. Join us as two leading investigators highlight emerging opportunities to identify and exploit cancer-specific vulnerabilities, advancing the development of innovative precision therapies. Register: ow.ly/tIw150ZMI8w #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 15/09/2026

How will AI affect the role of reviewers in scientific publishing? For Peer Review Week 2026, we asked Beverley Greenwood-Van Meerveld, editor-in-chief of JPET, for her thoughts. And learn more about JPET here: jpet.aspetjournals.org #peerreviewweek #peerreview #prw2026 #pharmsky 🧪

051

ASPET Journals @aspetjournals.bsky.social · 14/09/2026

Happy Peer Review Week 2026 🎉! We asked Xinxin Ding, PhD, to share his thoughts on AI on Drug Metabolism and Disposition (DMD). Learn more about DMD: dmd.aspetjournals.org #peerreviewweek #peerreview #prw2026 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 14/09/2026

Don't miss your chance to break into the world of scientific publishing! Applications for the ASPET Editorial Fellowship program close this Friday. Learn more: ow.ly/lz1L50ZM4gG #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 10/09/2026

Seeking your research! This special collection seeks to profile original research in all areas associated with gene and cell-based therapeutics for neurological disorders driven by maladaptive neuroplasticity. Submit your papers by November 25, 2026: ow.ly/7koe50ZIV0R #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 10/09/2026

Vikram Aditya, a PhD Candidate, is the Molecular Pharmacology HTA for September 2026. His research focuses on OATP1B1, one of the uptake transport proteins that helps move drugs from the blood into the liver cells and investigates whether KDAC6 can affect how it functions: ow.ly/oGxI50ZIW2X

000

ASPET Journals @aspetjournals.bsky.social · 09/09/2026

📢 Sign up for tomorrow's webinar, and explore how mechanistic pharmacokinetic-pharmacodynamic (PKPD) modeling can advance the development of next-generation antibody-based therapeutics. Learn more and sign up: ow.ly/14y350ZKFJ3 ow.ly/14y350ZKFJ3 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 08/09/2026

Are you a senior post-doctoral fellow or junior faculty member with relevant expertise in pharmacology and drug development? Interested in building important skills as a peer reviewer or editor? Apply for the ASPET Editorial Fellowship program: bit.ly/4xETeTx #pharmsky 🧪

001

ASPET Journals @aspetjournals.bsky.social · 07/09/2026

JPET's recent Editor's Choice shows how new data obtained may aid drug discovery and design efforts to help better understand the structural determinants of the potent opioid-like effects of nitazenes. Read the research: ow.ly/OrK050ZJsiS #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 03/09/2026

This study revealed plasma ezetimibe-glucuronide, following a subtherapeutic dose of ezetimibe, as a biomarker for MASH-associated transporter dysfunction and hepatocyte ballooning, underscoring its potential in clinical diagnosis. Read our Editor's Choice: ow.ly/tXqZ50ZIgFY #pharmsky 🧪

031

ASPET Journals @aspetjournals.bsky.social · 02/09/2026

We've extended the deadline for our upcoming special collection, "2025 New Frontiers in GPCR Signaling: Emerging Investigator Highlights!" Submit your work by October 31, and learn more at ow.ly/oZRH50ZHHcq #pharmsky 🧪

020

ASPET Journals @aspetjournals.bsky.social · 31/08/2026

JPET is planning a collection highlighting innovative frameworks that move beyond static models toward dynamic, systems-level modulation of signaling networks, enabling the rational design of effective & safe therapeutics for complex neurodegenerative disorders: ow.ly/R6ZR50ZHlqc #pharmsky 🧪

031

ASPET Journals @aspetjournals.bsky.social · 31/08/2026

The ASPET Editorial Fellowship program is a one-year program designed to build important skills as a peer reviewer and as an editor. Applications due September 18! Learn more and apply now: bit.ly/4xETeTx #pharmsky 🧪

011

ASPET Journals @aspetjournals.bsky.social · 28/08/2026

Explore ASPET’s 2025-26 Washington Fellows' written policy briefs! This year’s class focused on a diverse variety of issues to further their interest in government and science policy, culminating in actionable policy briefs. 🔗 ow.ly/7iWR50ZG5aS

000

ASPET Journals @aspetjournals.bsky.social · 27/08/2026

Learn more and contribute your research to the JPET section "Clinical Pharmacology," a necessity for advancing medical knowledge and improving patient care: www.aspet.org/aspet/news/news/2026/… #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 27/08/2026

Register now for our upcoming webinar! This discussion will illustrate how quantitative pharmacology can elucidate drug disposition, target engagement, and therapeutic response for complex biologics. Learn more and sign up: ow.ly/VaHq50ZESF9 #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 26/08/2026

This special collection in JPET seeks to profile original research in all areas associated with gene and cell-based therapeutics for neurological disorders driven by maladaptive neuroplasticity. 📢 Submit your research by November 25: ow.ly/weLH50ZFcXI #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 25/08/2026

In our recent Editor's Choice, preclinical data suggest that DSP-2342 may be an effective treatment for BPSD while providing cognitive improvement, and provide strong evidence to move towards human trials. Read and share the research: ow.ly/S8Ux50ZENX3 #pharmsky 🧪

010

ASPET Journals @aspetjournals.bsky.social · 25/08/2026

Are you interested in learning how your organization can best advocate for science policy with elected officials, educational or industry decision-makers, or the general public? We'll provide on-hands guidance on how your voice can be heard. Learn more: ow.ly/T7zi50ZBWNA #pharmsky 🧪

000

ASPET Journals @aspetjournals.bsky.social · 24/08/2026

Interested in publishing your research in an open access journal that welcomes rigorous computational studies advancing pharmacology, therapeutics, and drug discovery? Learn more about ASPET Discovery! www.aspetdiscovery.org #pharmsky 🧪

000